Ident. | Authors (with country if any) | Title |
---|
000040 (2013) |
Isabelle Boileau [Canada, Niger] ; Doris Payer [Canada] ; Bindiya Chugani [Canada] ; Daniela Lobo [Canada] ; Arian Behzadi [Canada] ; Pablo M. Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jerry Warsh [Canada] ; Stephen J. Kish [Canada] ; Martin Zack [Canada] | The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]‐(+)‐propyl‐hexahydro‐naphtho‐oxazin and [11C]raclopride |
000201 (2012) |
Christian Pifl [Autriche] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] | Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non‐motor symptoms |
000524 (2010) |
Junchao Tong [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon] | Brain -synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation |
000597 (2010) |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders |
000702 (2009) |
Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada] | Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease |
000841 (2008) |
Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] | Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease |
000932 (2008) |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB |
000D25 (2004) |
Anna Moszczynska ; Paul Fitzmaurice ; Lee Ang ; Kathryn S. Kalasinsky ; Gregory A. Schmunk ; Frank J. Peretti ; Sally S. Aiken ; Dennis J. Wickham [États-Unis] ; Stephen J. Kish | Why is parkinsonism not a feature of human methamphetamine users? |
000E01 (2004) |
Junchao Tong [Canada] ; Paul S. Fitzmaurice ; Lee Cyn Ang [Royaume-Uni] ; Yoshiaki Furukawa [Canada] ; Mark Guttman ; Stephen J. Kish | Brain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy |
000E46 (2003) |
Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] | Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease |
000F42 (2002) |
Yoshiaki Furukawa [Canada] ; Gregory Kapatos [États-Unis] ; John W. Haycock [États-Unis] ; Julian Worsley [Canada] ; Henry Wong [Canada] ; Stephen J. Kish [Canada] ; Torbjoern G. Nygaard [États-Unis] | Brain biopterin and tyrosine hydroxylase in asymptomatic dopa‐responsive dystonia |
001233 (2000) |
Yoshiaki Furukawa [Canada] ; Mark Guttman [Canada] ; Steven P. Sparagana [États-Unis] ; Joel M. Trugman [États-Unis] ; Keith Hyland [États-Unis] ; Philip Wyatt [Canada] ; Anthony E. Lang [Canada] ; Guy A. Rouleau [Canada] ; Mitsunobu Shimadzu [Japon] ; Stephen J. Kish [Canada] | Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene |
001536 (1998) |
Kelly Macmillan Muenter [États-Unis] ; Lysia S. Forno [États-Unis] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] ; Demetrius M. Maraganore [États-Unis] ; Richard J. Caselli [États-Unis] ; Haruo Okazaki [États-Unis] ; Frank M. Howard Jr. [États-Unis] ; Barry J. Snow [Nouvelle-Zélande] ; Donald B. Calne [Canada] | Hereditary form of parkinsonism—dementia |
001544 (1998) |
Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] ; E. Martina Bebin [États-Unis] ; Richard D. Jacobson [États-Unis] ; Julie S. Fryburg [États-Unis] ; Willam G. Wilson [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Keith Hyland [États-Unis] ; Keith Trugman [États-Unis] | Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations |
001851 (1996) |
Michel P. Furukawa [Japon, Canada] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Yumiko Shimuzu [Japon] ; Tetsuzo Tagawa [Japon] ; Hideo Mori [Japon] ; Masayuki Yokochi [Japon] ; Hirotaro Narabayashi [Japon] ; Oleh Hornykiewicz [Autriche] ; Yoshikuni Mizuno [Japon] ; Stephen J. Kish [Canada] | GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia |
002297 (1988) |
Douglas S. Gilbert [Canada] ; Stephen J. Kish [Canada] ; Li-Jan Chang [Canada] ; Caryl Morito [Canada] ; Kathleen Shannak [Canada] ; Oleh Hornykiewicz [Canada, Autriche] | Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates |
002371 (1987) |
Thomas L. Perry [Canada] ; Voon Wee Yong [Canada] ; William J. Godolphin [Canada] ; Michelle Sutter [Canada] ; Shirley Hansen [Canada] ; Stephen J. Kish [Canada] ; James G. Foulks [Canada] ; Masatoshi Ito [Canada] | Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration |
002508 (1985) |
Stephen J. Kish [Canada] ; Caryl Morito [Canada] ; Oleh Hornykiewicz [Canada] | Glutathione peroxidase activity in Parkinson's disease brain |
002525 (1985) |
Thomas L. Perry ; Voon Wee Yong ; Masatoshi Ito ; Karen Jones ; Richard A. Wall ; James G. Foulks ; James M. Wright ; Stephen J. Kish | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig |